LifeVantage (NASDAQ:LFVN) Shares Pass Below 200-Day Moving Average of $6.49

LifeVantage Co. (NASDAQ:LFVNGet Free Report)’s stock price crossed below its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $6.49 and traded as low as $6.27. LifeVantage shares last traded at $6.27, with a volume of 47,333 shares.

LifeVantage Stock Performance

The stock has a market cap of $80.68 million, a PE ratio of 27.26 and a beta of 0.80. The stock’s 50-day moving average is $6.43 and its two-hundred day moving average is $6.49.

LifeVantage (NASDAQ:LFVNGet Free Report) last posted its quarterly earnings data on Tuesday, January 30th. The company reported $0.10 earnings per share for the quarter. The firm had revenue of $51.62 million during the quarter. LifeVantage had a net margin of 1.40% and a return on equity of 19.96%.

LifeVantage Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were given a $0.035 dividend. The ex-dividend date was Thursday, February 29th. This represents a $0.14 annualized dividend and a yield of 2.23%. LifeVantage’s dividend payout ratio is presently 60.87%.

Hedge Funds Weigh In On LifeVantage

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. American Century Companies Inc. raised its holdings in shares of LifeVantage by 30.3% in the 1st quarter. American Century Companies Inc. now owns 46,016 shares of the company’s stock valued at $219,000 after purchasing an additional 10,706 shares in the last quarter. BlackRock Inc. grew its stake in shares of LifeVantage by 10.5% during the first quarter. BlackRock Inc. now owns 249,547 shares of the company’s stock worth $1,188,000 after purchasing an additional 23,788 shares in the last quarter. Dimensional Fund Advisors LP grew its stake in shares of LifeVantage by 4.6% during the first quarter. Dimensional Fund Advisors LP now owns 271,614 shares of the company’s stock worth $1,293,000 after purchasing an additional 11,964 shares in the last quarter. State Street Corp grew its stake in shares of LifeVantage by 7.6% during the first quarter. State Street Corp now owns 46,191 shares of the company’s stock worth $220,000 after purchasing an additional 3,281 shares in the last quarter. Finally, EP Wealth Advisors LLC purchased a new stake in LifeVantage in the first quarter valued at $234,000. Hedge funds and other institutional investors own 35.66% of the company’s stock.

About LifeVantage

(Get Free Report)

LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care, bath and body, and targeted relief products. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; PhysIQ, a weight management system; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix.

Read More

Receive News & Ratings for LifeVantage Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LifeVantage and related companies with MarketBeat.com's FREE daily email newsletter.